The Current Place of Tranexamic Acid in the Elective Hip
Arthroplasty

D 2022

The Current Place of Tranexamic Acid in the Elective Hip Arthroplasty

NACHTNEBL, Luboš a Vasileios APOSTOLOPOULOS

Základní údaje

Originální název

The Current Place of Tranexamic Acid in the Elective Hip Arthroplasty

Autoři

NACHTNEBL, Luboš (203 Česká republika, garant, domácí) a Vasileios APOSTOLOPOULOS (203 Česká republika, domácí)

Vydání

Brno, Noninvasive methods in cardiology 2022, od s. 77-81, 5 s. 2022

Nakladatel

Masaryk University Press

Další údaje

Jazyk

angličtina

Typ výsledku

Stať ve sborníku

Obor

30211 Orthopaedics

Stát vydavatele

Česká republika

Utajení

není předmětem státního či obchodního tajemství

Forma vydání

tištěná verze "print"

Odkazy

URL

Kód RIV

RIV/00216224:14110/22:00128528

Organizační jednotka

Lékařská fakulta

ISBN

978-80-280-0170-4

Klíčová slova anglicky

Elective Hip Arthroplasty; Tranexamic Acid

Štítky

rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 3. 2. 2023 10:08, Mgr. Tereza Miškechová

Anotace

V originále

The total hip arthroplasties (ΤΗΑ) are associated with perioperative blood losses exceeding 500 mL, some studies claim average blood losses of up to 1500Ml [1]. Blood loss volumes are certainly strongly dependent on the chosen surgical approach and technique. Approximately 30% of patients that undergo elective hip replacement receive at least one blood unit in postoperative care [2]. Reducing blood losses has a beneficial impact on recovery time, length of stay, and health economics. In the last decade, there has been an increasing interest in the efficacy of tranexamic acid (TXA) in orthopaedics and especially in elective major joint replacements. Highlighted advantages of the TXA in hip replacement surgery are the systemic or local prevention of hemorrhage and the prevention of heterotopic ossification formation. This paper presents an overview of our current understanding of the use of TXA in elective hip replacement.

Citovat

NACHTNEBL, Luboš a Vasileios APOSTOLOPOULOS. The Current Place of Tranexamic Acid in the Elective Hip Arthroplasty. In Cornélissen G., Siegelová J., Dobšák P. Noninvasive methods in cardiology 2022. Brno: Masaryk University Press, 2022, s. 77-81. ISBN 978-80-280-0170-4.

@inproceedings{2252412,
   author = {Nachtnebl, Luboš and Apostolopoulos, Vasileios},
   address = {Brno},
   booktitle = {Noninvasive methods in cardiology 2022},
   editor = {Cornélissen G., Siegelová J., Dobšák P.},
   keywords = {Elective Hip Arthroplasty; Tranexamic Acid},
   howpublished = {tištěná verze "print"},
   language = {eng},
   location = {Brno},
   isbn = {978-80-280-0170-4},
   pages = {77-81},
   publisher = {Masaryk University Press},
   title = {The Current Place of Tranexamic Acid in the Elective Hip Arthroplasty},
   url = {https://is.muni.cz/do/med/noninvasive_methods_in_cardiology/Noninvasive_methods_in_cardiology_2022.pdf},
   year = {2022}
}

TY  - JOUR
ID  - 2252412
AU  - Nachtnebl, Luboš - Apostolopoulos, Vasileios
PY  - 2022
TI  - The Current Place of Tranexamic Acid in the Elective Hip Arthroplasty
PB  - Masaryk University Press
CY  - Brno
SN  - 9788028001704
KW  - Elective Hip Arthroplasty
KW  - Tranexamic Acid
UR  - https://is.muni.cz/do/med/noninvasive_methods_in_cardiology/Noninvasive_methods_in_cardiology_2022.pdf
N2  - The total hip arthroplasties (ΤΗΑ) are associated with perioperative blood losses exceeding 500 mL, some studies claim average blood losses of up to 1500Ml [1]. Blood loss volumes are certainly strongly dependent on the chosen surgical approach and technique. Approximately 30% of patients that undergo elective hip replacement receive at least one blood unit in postoperative care [2]. Reducing blood losses has a beneficial impact on recovery time, length of stay, and health economics. In the last decade, there has been an increasing interest in the efficacy of tranexamic acid (TXA) in orthopaedics and especially in elective major joint replacements. Highlighted advantages of the TXA in hip replacement surgery are the systemic or local prevention of hemorrhage and the prevention of heterotopic ossification formation. This paper presents an overview of our current understanding of the use of TXA in elective hip replacement.
ER  -

NACHTNEBL, Luboš a Vasileios APOSTOLOPOULOS. The Current Place of Tranexamic Acid in the Elective Hip Arthroplasty. In Cornélissen G., Siegelová J., Dobšák P. \textit{Noninvasive methods in cardiology 2022}. Brno: Masaryk University Press, 2022, s.~77-81. ISBN~978-80-280-0170-4.

Podrobný výpis o publikaci